Login / Signup

In Vitro Biological Activity of Natural Products from the Endophytic Fungus Paraboeremia selaginellae against Toxoplasma gondii .

Flaminia MazzoneViktor E SimonsLasse van GeelenMarian FrankAttila MándiTibor KurtánKlaus PfefferRainer Kalscheuer
Published in: Antibiotics (Basel, Switzerland) (2022)
Toxoplasma gondii is an apicomplexan pathogen able to infect a wide range of warm-blooded animals, including humans, leading to toxoplasmosis. Current treatments for toxoplasmosis are associated with severe side-effects and a lack efficacy to eradicate chronic infection. Thus, there is an urgent need for developing novel, highly efficient agents against toxoplasmosis with low toxicity. For decades, natural products have been a useful source of novel bioactive compounds for the treatment of infectious pathogens. In the present study, we isolated eight natural products from the crude extract of the endophytic fungus Paraboeremia selaginellae obtained from the leaves of the plant Philodendron monstera . The natural products were tested for inhibiting Toxoplasma gondii proliferation, and their cytotoxicity was evaluated in different human cell lines. Six natural products showed antitoxoplasma activity with low or no cytotoxicity in human cell lines. Together, these findings indicate that biphenyl ethers, bioxanthracenes, and 5 S ,6 S -phomalactone from P. selaginellae are potential candidates for novel anti-toxoplasma drugs.
Keyphrases
  • toxoplasma gondii
  • highly efficient
  • endothelial cells
  • signaling pathway
  • oxidative stress
  • induced pluripotent stem cells
  • pluripotent stem cells
  • early onset
  • drug induced
  • candida albicans
  • combination therapy